WORLD KIDNEY DAY-2017 |
C.P. Kovesdy, S. Furth, C. Zoccali
Obesity and kidney disease: hidden consequences of the epidemic
|
3-11 |
ORIGINAL PAPERS |
Y.V. Korotchaeva, N.L. Kozlovskaya, K.A. Demyanova, L.A. Bobrova, P.A. Shatalov, D. Korostin, V.V. Linsky, D.I. Borisevich, A.U. Krasnenko
Genetic aspects of obstetric atypical hemolytic uremic syndrome
|
12-17 |
E.V. Bolotova, A.V. Dudnikova, V.V. Yavlyanskaya
Features of chronic kidney disease diagnosis in patients with chronic obstructive pulmonary disease
|
18-22 |
F.K. Akhmedov, V.E. Avakov, M.N. Negmatullaeva
Renal function and some indicators of homeostasis in women with pregnancy complicated by pre-eclampsia
|
23-26 |
A.V. Nikolaeva, L.T. Pimenov
Renal function and cardio-renal relationship in patients with primary hypothyroidism and concurrent arterial hypertension
|
27-30 |
A.G. Stolyar
Compliance as an important predictor of renal transplantation outcomes
|
31-35 |
A.V. Sokolova, D.O. Dragunov, G.P. Arutyunov
Urine conductivity as a screening test to detect an adverse circadian blood pressure profile
|
36-41 |
E.I. Prokopenko, E.S. Stolyarevich
The use of Everolimus as a part of maintenance immunosuppressive therapy in patients with minimal renal transplant dysfunction: results of a prospective observational program (crad001aru01)
|
42-48 |
CASE REPORTS |
N.L. Kozlovskaya, M.I. Akaeva, E.S. Stolyarevich, L.A. Bobrova, T.V. Bondarenko, A.M. Kuchieva
Thrombotic microangiopathy associated with malignant arterial hypertension
|
49-56 |
LITERATURE REVIEWS |
A.I. Dyadik, N.F. Yarovaya, Y.V. Suliman, S.R. Zborowskyy, V.I. Merkurev, T.E. Kugler
Chronic kidney disease and atrial fibrillation
|
57-60 |
O.N. Kotenko, T.V. Bondarenko
The approaches to the diagnosis and treatment of atypical hemolytic uremic syndrome in the practice of a nephrologist
|
61-64 |
V.Yu. Perfil'ev, Ya.F. Zverev, A.Yu. Zharikov
Insulin resistance as a risk factor for the development of uric acid nephrolithiasis
|
65-70 |
E.A. Gorelova, N.N. Chernysheva, O.N. Kotenko, E.V. Shutov
Contemporary opportunities for using phosphate binders in dialysis patients
|
71-80 |